The Manufacturers Life Insurance Company Invests $7.35 Million in Ralliant Corporation $RAL

The Manufacturers Life Insurance Company bought a new position in shares of Ralliant Corporation (NYSE:RAL) in the 2nd quarter, HoldingsChannel reports. The institutional investor bought 99,840 shares of the company’s stock, valued at approximately $7,351,000.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in RAL. BlackRock Inc. acquired a new stake in shares of Ralliant during the 2nd quarter worth approximately $1,039,481,000. Irenic Capital Management LP lifted its stake in shares of Ralliant by 424.1% in the 1st quarter. Irenic Capital Management LP now owns 1,740,218 shares of the company’s stock valued at $72,376,000 after purchasing an additional 1,408,176 shares during the period. Rokos Capital Management LLP acquired a new position in shares of Ralliant in the 1st quarter valued at $42,022,000. Flossbach Von Storch SE purchased a new stake in Ralliant during the second quarter worth $222,460,000. Finally, California State Teachers Retirement System boosted its holdings in Ralliant by 23.1% during the first quarter. California State Teachers Retirement System now owns 130,822 shares of the company’s stock worth $5,441,000 after buying an additional 24,591 shares in the last quarter.

Wall Street Analysts Forecast Growth

RAL has been the subject of a number of recent analyst reports. Vertical Research cut shares of Ralliant from a “buy” rating to a “hold” rating and set a $65.00 price objective for the company. in a report on Wednesday, May 27th. Morgan Stanley raised their target price on Ralliant from $68.00 to $85.00 and gave the company an “overweight” rating in a research report on Tuesday, June 23rd. Oppenheimer lifted their price target on Ralliant from $50.00 to $65.00 and gave the company an “outperform” rating in a research note on Wednesday, May 13th. Truist Financial reiterated a “buy” rating and set a $82.00 price target (up from $68.00) on shares of Ralliant in a research report on Friday, July 31st. Finally, Evercore assumed coverage on Ralliant in a report on Tuesday, June 9th. They issued an “outperform” rating and a $80.00 price objective on the stock. One equities research analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, three have given a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, Ralliant has a consensus rating of “Moderate Buy” and a consensus price target of $75.70.

Ralliant Stock Performance

NYSE RAL opened at $61.65 on Monday. The company has a debt-to-equity ratio of 0.75, a current ratio of 1.52 and a quick ratio of 1.00. The stock’s 50 day simple moving average is $68.40 and its 200-day simple moving average is $56.53. The company has a market cap of $6.82 billion, a PE ratio of -5.68, a price-to-earnings-growth ratio of 2.29 and a beta of 1.61. Ralliant Corporation has a 1-year low of $37.27 and a 1-year high of $75.41.

Ralliant (NYSE:RAL) last issued its quarterly earnings results on Thursday, July 30th. The company reported $0.68 EPS for the quarter, topping the consensus estimate of $0.63 by $0.05. The firm had revenue of $567.80 million during the quarter. Ralliant had a positive return on equity of 14.97% and a negative net margin of 56.38%.Ralliant has set its FY 2026 guidance at 2.760-2.900 EPS and its Q3 2026 guidance at 0.720-0.780 EPS. As a group, equities research analysts anticipate that Ralliant Corporation will post 2.87 EPS for the current fiscal year.

Ralliant Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, September 23rd. Stockholders of record on Tuesday, September 8th will be paid a $0.05 dividend. This represents a $0.20 annualized dividend and a dividend yield of 0.3%. The ex-dividend date of this dividend is Tuesday, September 8th. Ralliant’s dividend payout ratio (DPR) is currently -1.84%.

Insider Transactions at Ralliant

In other Ralliant news, SVP Karen M. Bick sold 6,062 shares of the firm’s stock in a transaction that occurred on Monday, August 17th. The shares were sold at an average price of $72.00, for a total value of $436,464.00. Following the transaction, the senior vice president directly owned 31,668 shares of the company’s stock, valued at $2,280,096. This trade represents a 16.07% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Tamara S. Newcombe sold 12,936 shares of the business’s stock in a transaction that occurred on Friday, August 14th. The stock was sold at an average price of $71.79, for a total value of $928,675.44. Following the transaction, the chief executive officer owned 251,967 shares in the company, valued at approximately $18,088,710.93. This represents a 4.88% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders own 0.42% of the company’s stock.

Ralliant Profile

Ralliant, Inc (NYSE: RAL) is a medical technology company focused on enabling point-of-care cell therapy solutions in the field of regenerative medicine. The company develops and markets systems that isolate, concentrate and store adipose-derived stromal vascular fraction (SVF) cells directly from a patient’s own fat tissue, facilitating same-day, autologous treatments without the need for extensive laboratory infrastructure.

The company’s core product portfolio includes proprietary device platforms and single-use processing kits engineered to streamline the workflow for clinicians.